Compare Phillips 66 (PSX) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Phillips 66 vs Smith & Nephew plc — how do they compare? Phillips 66 trades at $262.99 (market cap $104.06B), while Smith & Nephew plc trades at $27.96 (market cap $11.62B). The key difference: Phillips 66 is far larger — about 9× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.86%). Which is the better fit depends on your goals.
| PSX | SNN | |
|---|---|---|
Market Cap | $104.06B | $11.62B |
Sector | Energy | Health |
52-Week High | $260.78 | $38.53 |
52-Week Low | $126.76 | $27.80 |
Enterprise Value | $120.52B | $14.66B |
Dividend Yield | 1.95% | 2.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Phillips 66 (PSX) trades at $259.14, up 1.59% over 24 hours and near its 52-week high, with bullish technical indicators and strong support at $258. The stock shows robust fundamentals, including a P/E of 14.79 and ROE of 24.02%, while recent quarterly earnings consistently beat expectations. Positive news highlights refining strength amid elevated energy prices, with institutional buying supporting momentum.
Outlook remains favorable due to earnings growth and cost initiatives, but risks include volatile refining margins and debt levels. Analysts are bullish with a $242.45 consensus target, though current price exceeds it, suggesting cautious optimism for further upside if operational targets are met.
SNN trades at $27.87, down 3.46% today and near a 52-week low. Technical indicators are bearish, but oversold RSI levels suggest potential for a rebound. Fundamentally, the company shows strong revenue growth to $6.16 billion in 2025 and a net income margin of 10.08%, though recent guidance cuts and CFO departure have weighed on sentiment. A dividend of $0.31 is scheduled for payment in November 2026.
The outlook is cautious due to competitive pressures and execution risks, but valuation metrics like a P/E of 18.96 appear reasonable. Analyst consensus is Hold, with 65% recommending neutrality. Upside depends on improved operational performance and stabilization in key markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Phillips 66
Phillips 66 is an independent refiner with 12 refineries that have a total crude throughput capacity of 2.0 million barrels per day, or mmb/d, after converting its 255 mb/d Alliance refinery to a terminal. The midstream segment comprises extensive transportation and NGL processing assets. It also includes its DCP Midstream joint venture, which holds 45 natural gas processing facilities, 11 NGL fractionation plants, and a natural gas pipeline system with 58,000 miles of pipeline. Its CPChem chemical joint venture operates facilities in the United States and the Middle East and primarily produces olefins and polyolefins.
Read more on PSX →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
